Adherence to, and effectiveness of, subcutaneous interferon beta-1a administered by RebiSmart (R) in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study

Antonios Bayas*, Jean Christophe Ouallet, Boris Kallmann, Raymond Hupperts, Ulrich Fulda, Kurt Marhardt

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

28 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1239-1250
JournalExpert Opinion on Drug Delivery
Issue number8
Publication statusPublished - Aug 2015


  • adherence
  • autoinjector
  • interferon beta
  • multiple sclerosis

Cite this